(Q44092843)

29 November 2017

Absence of interaction between oxcarbazepine and erythromycin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1414219

24 September 2022

author name string

T. Keränen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1414219

24 September 2022

J. Jolkkonen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1414219

24 September 2022

P. K. Jensen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1414219

24 September 2022

G. P. Menge

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1414219

24 September 2022

P. Andersson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1414219

24 September 2022

language of work or name

English

0 references

publication date

1 August 1992

1 reference

Acta Neurologica Scandinavica

29 November 2017

1 reference

29 November 2017

86

1 reference

29 November 2017

2

1 reference

29 November 2017

120-123

1 reference

Inhibition by erythromycin of the conversion of carbamazepine to its active 10,11-epoxide metabolite

29 November 2017

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1600-0404.1992.TB05051.X

Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1600-0404.1992.TB05051.X

10.1111/J.1600-0404.1992.TB05051.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference